Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

53 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Left atrial appendage occlusion versus standard medical care in patients with atrial fibrillation and intracerebral haemorrhage: a propensity score-matched follow-up study.
Nielsen-Kudsk JE, Johnsen SP, Wester P, Damgaard D, Airaksinen J, Lund J, De Backer O, Pakarinen S, Odenstedt J, Vikman S, Settergren M, Kongstad O, Rosenqvist M, Krieger DW. Nielsen-Kudsk JE, et al. Among authors: kongstad o. EuroIntervention. 2017 Jun 20;13(3):371-378. doi: 10.4244/EIJ-D-17-00201. EuroIntervention. 2017. PMID: 28485276 Free article.
The Medical ANtiarrhythmic Treatment or Radiofrequency Ablation in Paroxysmal Atrial Fibrillation (MANTRA-PAF) trial: clinical rationale, study design, and implementation.
Jons C, Hansen PS, Johannessen A, Hindricks G, Raatikainen P, Kongstad O, Walfridsson H, Pehrson S, Almroth H, Hartikainen J, Petersen AK, Mortensen LS, Nielsen JC; MANTRA-PAF Investigators. Jons C, et al. Among authors: kongstad o. Europace. 2009 Jul;11(7):917-23. doi: 10.1093/europace/eup122. Epub 2009 May 15. Europace. 2009. PMID: 19447807 Clinical Trial.
Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation.
Cosedis Nielsen J, Johannessen A, Raatikainen P, Hindricks G, Walfridsson H, Kongstad O, Pehrson S, Englund A, Hartikainen J, Mortensen LS, Hansen PS. Cosedis Nielsen J, et al. Among authors: kongstad o. N Engl J Med. 2012 Oct 25;367(17):1587-95. doi: 10.1056/NEJMoa1113566. N Engl J Med. 2012. PMID: 23094720 Free article. Clinical Trial.
The cost-effectiveness of radiofrequency catheter ablation as first-line treatment for paroxysmal atrial fibrillation: results from a MANTRA-PAF substudy.
Aronsson M, Walfridsson H, Janzon M, Walfridsson U, Nielsen JC, Hansen PS, Johannessen A, Raatikainen P, Hindricks G, Kongstad O, Pehrson S, Englund A, Hartikainen J, Mortensen LS, Levin LÅ. Aronsson M, et al. Among authors: kongstad o. Europace. 2015 Jan;17(1):48-55. doi: 10.1093/europace/euu188. Epub 2014 Oct 23. Europace. 2015. PMID: 25341739 Free article. Clinical Trial.
Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation: results on health-related quality of life and symptom burden. The MANTRA-PAF trial.
Walfridsson H, Walfridsson U, Nielsen JC, Johannessen A, Raatikainen P, Janzon M, Levin LA, Aronsson M, Hindricks G, Kongstad O, Pehrson S, Englund A, Hartikainen J, Mortensen LS, Hansen PS. Walfridsson H, et al. Among authors: kongstad o. Europace. 2015 Feb;17(2):215-21. doi: 10.1093/europace/euu342. Epub 2015 Jan 6. Europace. 2015. PMID: 25567068 Clinical Trial.
Radiofrequency catheter ablation maintains its efficacy better than antiarrhythmic medication in patients with paroxysmal atrial fibrillation: On-treatment analysis of the randomized controlled MANTRA-PAF trial.
Raatikainen MJ, Hakalahti A, Uusimaa P, Nielsen JC, Johannessen A, Hindricks G, Walfridsson H, Pehrson S, Englund A, Hartikainen J, Kongstad O, Mortensen LS, Hansen PS; MANTRA-PAF investigators. Raatikainen MJ, et al. Among authors: kongstad o. Int J Cardiol. 2015 Nov 1;198:108-14. doi: 10.1016/j.ijcard.2015.06.160. Epub 2015 Jul 4. Int J Cardiol. 2015. PMID: 26163901 Clinical Trial.
Higher burden of supraventricular ectopic complexes early after catheter ablation for atrial fibrillation is associated with increased risk of recurrent atrial fibrillation.
Alhede C, Johannessen A, Dixen U, Jensen JS, Raatikainen P, Hindricks G, Walfridsson H, Kongstad O, Pehrson S, Englund A, Hartikainen J, Hansen PS, Nielsen JC, Jons C. Alhede C, et al. Among authors: kongstad o. Europace. 2018 Jan 1;20(1):50-57. doi: 10.1093/europace/euw329. Europace. 2018. PMID: 28011799 Clinical Trial.
Antiarrhythmic medication is superior to catheter ablation in suppressing supraventricular ectopic complexes in patients with atrial fibrillation.
Alhede C, Lauridsen TK, Johannessen A, Dixen U, Jensen JS, Raatikainen P, Hindricks G, Walfridsson H, Kongstad O, Pehrson S, Englund A, Hartikainen J, Hansen PS, Nielsen JC, Jons C. Alhede C, et al. Among authors: kongstad o. Int J Cardiol. 2017 Oct 1;244:186-191. doi: 10.1016/j.ijcard.2017.05.028. Epub 2017 May 10. Int J Cardiol. 2017. PMID: 28506548 Clinical Trial.
The impact of supraventricular ectopic complexes in different age groups and risk of recurrent atrial fibrillation after antiarrhythmic medication or catheter ablation.
Alhede C, Lauridsen TK, Johannessen A, Dixen U, Jensen JS, Raatikainen P, Hindricks G, Walfridsson H, Kongstad O, Pehrson S, Englund A, Hartikainen J, Hansen PS, Nielsen JC, Jons C. Alhede C, et al. Among authors: kongstad o. Int J Cardiol. 2018 Jan 1;250:122-127. doi: 10.1016/j.ijcard.2017.09.208. Epub 2017 Oct 9. Int J Cardiol. 2018. PMID: 29050922 Clinical Trial.
53 results